These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9789212)

  • 1. Biogenic amines as predictors of response to clozapine treatment in early-onset schizophrenia.
    Fleischhaker C; Schulz E; Remschmidt H
    J Psychiatr Res; 1998; 32(5):325-33. PubMed ID: 9789212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
    Fleischhaker C; Schulz E; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 1998 Dec; 26(4):235-43. PubMed ID: 9880833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
    Schulz E; Remschmidt H; Fleischhaker C
    Z Kinder Jugendpsychiatr; 1994 Dec; 22(4):285-98. PubMed ID: 7856324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlated changes in symptoms and neurotransmitter indices during maintenance treatment with clozapine or conventional neuroleptics in adolescents and young adults with schizophrenia.
    Schulz E; Fleischhaker C; Remschmidt HE
    J Child Adolesc Psychopharmacol; 1996; 6(2):119-31. PubMed ID: 9231304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia.
    Frazier JA; Gordon CT; McKenna K; Lenane MC; Jih D; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):658-63. PubMed ID: 8056728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine in the treatment of a young adolescent with schizophrenia.
    Jacobsen LK; Walker MC; Edwards JE; Chappell PB; Woolston JL
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):645-50. PubMed ID: 8056727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine treatment in very early onset schizophrenia.
    Mozes T; Toren P; Chernauzan N; Mester R; Yoran-Hegesh R; Blumensohn R; Weizman A
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):65-70. PubMed ID: 8138523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
    Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
    Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term clinical experience with clozapine].
    Gelly F; Chambon O; Marie-Cardine M
    Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels.
    Ertugrul A; Ucar G; Basar K; Demir B; Yabanoglu S; Ulug B
    Psychiatry Res; 2007 Jan; 149(1-3):49-57. PubMed ID: 17157920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
    Dursun SM; Szemis A; Andrews H; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
    Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
    J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical neuroleptics in the child and adolescent].
    Naja WJ; Reneric JP; Bouvard MP
    Encephale; 1998; 24(4):378-85. PubMed ID: 9809243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome.
    Towbin KE; Dykens EM; Pugliese RG
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):651-7. PubMed ID: 7520035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O; Weiner RD; McEvoy JP
    Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics.
    Mäkikyrö T; Leinonen E; Koponen H; Järvelin MR; Hakko H; Saarnisaari O; Isohanni M
    J Psychiatr Res; 1998; 32(2):105-10. PubMed ID: 9694006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.